Research Article
Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
Table 2
The median percentages of corneal neovascularization and maximum density of neovascularization (histopathological examination) in groups.
| | | Group 1
Topical tigecycline | Group 2
Topical 0.9% saline | Group 3
Subconjunctival tigecycline | Group 4
Subconjunctival 0.9% saline |
| | Neovasculized area (CI) | 48 (44.2–55.8) | 67 (55.8–75.2) | 33.5 (26.6–39.2) | 70 (67.3–73.4) | | Maximum density of neovascularization (CI) | 35.5 (21.6–49.4) | 66.5 (47.5–8.2) | 19.5 (12.3–30.2) | 57 (36.4–85.6) |
|
|
Results were defined as median values (95% confidence intervals (CI)).
|
